Galapagos Enters Into Discovery Collaboration With Idenix for Infectious Disease Programs
24. November 2005 02:12 ET
|
Galapagos Genomics
MECHELEN, Belgium, Nov. 24, 2005 (PRIMEZONE) -- Galapagos NV (Euronext:GLPG) (LSE:GLPG) announced today that it has entered into a collaboration with Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) on...
Galapagos Announces Third Quarter 2005 Results
10. November 2005 02:26 ET
|
Galapagos Genomics
-- Acquisition of BioFocus completed, integration progresses as
planned
-- Galapagos year to date revenues 8% below last year's revenues,
but cash burn in line with forecast
--...
Galapagos Appoints David Smith as Chief Financial Officer
09. November 2005 02:24 ET
|
Galapagos Genomics
MECHELEN, Belgium, Nov. 9, 2005 (PRIMEZONE) -- Galapagos (Euronext:GLPG) (LSE:GLPG), a genomics-based drug discovery company, has appointed David R. Smith as Chief Financial Officer to Galapagos per...
Galapagos to Release Third Quarter Results on 10 November 2005
02. November 2005 04:06 ET
|
Galapagos Genomics
MECHELEN, Belgium, Nov. 2, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company (Euronext Brussels, GLPG; Euronext Amsterdam, GLPGA, London AiM: GLPG) announced today that it...
Galapagos Expands Its Collaboration With Serono
18. Oktober 2005 02:09 ET
|
Galapagos Genomics
MECHELEN, Belgium, Oct. 18, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam: GLPGA) announced today that its services division BioFocus has reached agreement with the...
Galapagos Featured in Leading Drug Discovery Journal
14. Oktober 2005 02:07 ET
|
Galapagos Genomics
MECHELEN, Belgium, Oct. 14, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces that an article presenting the Company's approach to target discovery will appear in...
Galapagos Declares the Offer for BioFocus Unconditional as to Acceptances
13. Oktober 2005 05:30 ET
|
Galapagos Genomics
MECHELEN, Belgium, Oct. 13, 2005 (PRIMEZONE) -- Galapagos (Euronext Brussels: GLPG) (Euronext Amsterdam - GLPGA) announces that on October 12, valid acceptances had been received for 12,552,464...
Galapagos Obtains U.S. Patent Protecting its Discovery Platform
07. Oktober 2005 02:49 ET
|
Galapagos Genomics
MECHELEN, Belgium and LEIDEN, Netherlands, Oct. 7, 2005 (PRIMEZONE) -- Galapagos (Euronext Amsterdam:GLPGA) (Euronext Brussels:GLPG), today announced that it received a Notice of Allowance of a third...
Galapagos to Webcast Analyst Day on Friday, October 7, 2005
03. Oktober 2005 11:40 ET
|
Galapagos Genomics
MECHELEN, Belgium and LEIDEN, Netherlands Oct. 3, 2005 (PRIMEZONE) -- Galapagos NV (Euronext Amsterdam: GLPGA, Euronext Brussels: GLPG), invites investors, the media and the general public to view a...
Galapagos, Amsterdam Molecular Therapeutics, Netherlands Institute for Brain Research and Vrije Universiteit Amsterdam Announce Collaboration to Develop Innovative Treatments for Traumatic Spinal Cord and Peripheral Nerve Injuries
14. September 2005 02:14 ET
|
Galapagos Genomics
LEIDEN and AMSTERDAM, Netherlands, Sept. 14, 2005 (PRIMEZONE) -- Galapagos, Amsterdam Molecular Therapeutics B.V. (AMT), the Netherlands Institute for Brain Research (NIBR), and the Vrije...